⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

NEWGEN - Fundamental Analysis: Financial Health & Valuation

← Back to List

⭐ Rating: 2.8

Last Updated Time : 13 Sept 26, 12:11 am

Key Parameters

⭐ Fundamental Rating: 2.8

ROE20.2 %
ROCE25.4 %
Stock P/E21.9
Industry PE20.6
PEG Ratio0.97
Debt to equity0.02
EPS20.8 ₹
Book Value115 ₹
Show all parameters (20 more)
Stock CodeNEWGEN
Market Cap7,149 Cr.
Current Price501 ₹
High / Low1,042 ₹
Dividend Yield1.20 %
Face Value10.0 ₹
DMA 50522 ₹
DMA 200594 ₹
Chg in FII Hold-0.70 %
Chg in DII Hold-0.70 %
PAT Qtr59.8 Cr.
PAT Prev Qtr110 Cr.
RSI40.1
MACD-6.08
Volume6,19,961
Avg Vol 1Wk5,81,965
Low price401 ₹
High price1,042 ₹
52w Index15.7 %
Qtr Profit Var22.8 %

🏭 Industry

The Information Technology (IT) services sector is characterized by high growth potential and competitive intensity; however, margins can be sensitive to macroeconomic conditions and pricing pressure from larger players. Companies within this sector typically require substantial capital expenditure for technology upgrades and expansion, impacting cash flow dynamics.

✅ Positive

Newgen demonstrates robust profitability with a consistently high ROCE of 25.4% and solid cash flow generation reflected in its PAT growth, despite a recent decline. The company’s conservative capital structure, indicated by a debt-to-equity ratio of 0.02, provides flexibility and reduces financial risk.

⚠️ Limitation

The significant drop in PAT from the previous quarter raises concerns regarding short-term earnings volatility and warrants closer scrutiny of the underlying drivers. While the industry PE is relatively aligned with Newgen’s, the company's valuation metrics like P/E (21.9) are elevated compared to its peers, suggesting potential overvaluation given the recent profit decline.

📉 Company Negative News

Recent reports highlight a significant drop in PAT from 110 Cr. to 59.8 Cr., indicating a substantial contraction in earnings, which warrants investigation into the factors contributing to this decrease.

🧾 Long-Term Outlook

An entry zone would be around 460-480 ₹, representing a cautious approach accounting for the recent profit dip and elevated valuation relative to the industry. Long-term holding guidance is based on maintaining profitability; monitoring revenue growth and ensuring the sustainability of margins remains crucial. Overall, Newgen represents a cautiously optimistic investment with potential upside contingent upon execution against its strategic objectives and continued market share gains.

Choose Technical Analysis or Fundamental Analysis above to load it.

How NEWGEN Rates Across All Strategies

★ 4.2
Entry Price: 497 ₹.
★ 3.2
Buy at 495 ₹ with an initial stop-loss order set at 485 ₹.
★ 3.2
An ideal entry price zone would be between 460 ₹ and 485 ₹, represent…
Fundamental
★ 2.8
You're viewing this analysis below.

NIFTY 50 · Fundamental

NEXT 50 · Fundamental

MIDCAP · Fundamental

SMALLCAP · Fundamental